ImmunoGen, Inc - SWOT Analysis
ImmunoGen, Inc - SWOT Analysis - companiesandmarkets.com adds new report
© companiesandmarkets.com
27.11.2008 02:57:01 ImmunoGen, Inc - SWOT Analysis - a new market research report on www.companiesandmarkets.com
(live-PR.com) - www.companiesandmarkets.com/Summary-Company-Prof ..
Datamonitor´s ImmunoGen, Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company´s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
ImmunoGen develops targeted anticancer biopharmaceuticals. The company´s tumor-activated prodrug (TAP) technology uses tumor-targeting antibodies to deliver a
cell-killing agent specifically to cancer cells. ImmunoGen is headquartered in Cambridge, Massachusetts and employed 213 people as of June 30, 2007. The company recorded revenues of $38 million during the financial year (FY) ended June 2007, an increase of 19.1% over 2006. The increase in revenues was mainly due to higher revenues from R&D support and clinical materials reimbursement, as well as increases in license and milestone fees. The operating loss of the company was $22 million during FY2007, as compared to an operating loss of $21 million in 2006. The net loss was $19 million in FY2007, as compared to a net loss of $18 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company´s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers´ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors´ business structure, strategy and prospects
- Obtain the most up to date company information available
Datamonitor´s ImmunoGen, Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company´s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
ImmunoGen develops targeted anticancer biopharmaceuticals. The company´s tumor-activated prodrug (TAP) technology uses tumor-targeting antibodies to deliver a
|
|
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company´s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers´ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors´ business structure, strategy and prospects
- Obtain the most up to date company information available
| Author: |
